Q2 2025 Management View CEO Paul McKenzie announced a reaffirmation of guidance for fiscal 2025, targeting NPATA growth of 10% to 13%. He highlighted strong results from CSL Behring and growth in CSL ...
The ASX-listed pharmaceutical giant has shrugged off a sluggish period and says it expects profits to rise by more than 10 ...
Market Index News on MSN11h
CSL 1H25 Earnings Call HighlightsCSL (ASX: CSL) shares fell 4.9% on Tuesday following the company’s report of weaker-than-expected first-half revenue, net ...
CSL spectrograms can provide visual information useful in assessment. CSL files can be used to compare student and therapist productions. CSL files can be used to compare students to show that ...
UBS believes the CSL shares story is "heavily focused on gross profit margin improvement" at Behring. According to CSL, that division develops and delivers "high-quality medicines that treat ...
Today, the fund is underweight in CSL. Firetail said: Today our position is well below index weight due to our loss of confidence in the medium-term margin improvement story playing out as we had ...
Spanish defender Jose Martinez has joined Chinese Super League CSL club Yunnan Yukun as a free agent Effective as of today Spanish player Jose Ant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback